Leo L. Chan1,2 , Dee Shen3, Alisha R. Wilkinson1,2, Wayne Patton3, Ning Lai1, Eric Chan3, Dmitry Kuksin1,2, Bo Lin1, and Jean Qiu1
Grant Cameron, TAP
1Nexcelom Bioscience LLC, 360 Merrimack St. Building 9, Lawrence, MA 01843
2Center for Biotechnology and Biomedical Sciences, Merrimack College, North Andover, MA 01845
3Enzo Life Sciences, Farmingdale, NY 11735
Featured Product: CYTO-ID® Autophagy detection kit
INTRODUCTION
Autophagy is an important cellular catabolic process that plays a variety of important roles, including maintenance of the amino acid pool during starvation, recycling of damaged proteins and organelles, and clearance of intracellular microbes. Currently employed autophagy detection methods include fluorescence microscopy, biochemical measurement, SDS-PAGE, and Western blotting, but they are time-consuming, labor-intensive, and require much experience for accurate interpretation. More recently, development of novel fluorescent probes have allowed the investigation of autophagy via standard flow cytometry. However, flow cytometers remain relatively expensive and require a considerable amount of maintenance. Previously, image-based cytometry has been shown to perform automated fluorescence-based cellular analysis comparable to flow cytometry. In this study, we developed a novel method using the Cellometer image-based cytometer in combination with CYTO-ID® Green dye for autophagy detection in live cells. The method is compared to flow cytometry by measuring macroautophagy in nutrient-starved Jurkat cells. Results demonstrate similar trends of autophagic response, but different magnitudes of fluorescence signals increase, which may arise from different analysis approaches characteristic of the two instrument platforms. The possibility of using this method for drug discovery applications is also demonstrated through the measurement of dose-response kinetics upon induction of autophagy with rapamycin and tamoxifen. The described image-based cytometry/fluorescent dye method should serve as a useful addition to the current arsenal of techniques available in support of autophagy-based drug discovery relating to various pathological disorders